Publicação
Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases
| dc.contributor.author | Avram, A | |
| dc.contributor.author | Duarte, C | |
| dc.contributor.author | Santos, MJ | |
| dc.contributor.author | Papagoras, C | |
| dc.contributor.author | Ritis, K | |
| dc.contributor.author | Scarpioni, R | |
| dc.contributor.author | Schmidt, W | |
| dc.contributor.author | Skendros, P | |
| dc.date.accessioned | 2017-08-25T13:28:36Z | |
| dc.date.available | 2017-08-25T13:28:36Z | |
| dc.date.issued | 2015-10 | |
| dc.description.abstract | A subgroup of patients with gouty arthritis have a chronic recurring form that is particularly difficult to treat. Such patients experience repeated flares and often have abundant tophi. Many also have underlying comorbidities, such as renal impairment, cardiovascular disease, gastrointestinal disorders, obesity, and hypertension, which contraindicate the use of standard anti-inflammatory medications. Five patients with difficult to treat gouty arthritis who were either candidates and/or treated with anti-IL therapy are described. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Joint Bone Spine. 2015 Oct;82 Suppl 1:eS17-29. | pt_PT |
| dc.identifier.doi | 10.1016/S1297-319X(15)30004-X | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.4/2076 | |
| dc.language.iso | eng | pt_PT |
| dc.subject | Artrite Gotosa | pt_PT |
| dc.subject | Supressores da Gota | pt_PT |
| dc.subject | Interleucina-1 | pt_PT |
| dc.subject | Selecção de Doentes | pt_PT |
| dc.title | Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | eS17-29 | pt_PT |
| oaire.citation.volume | 82 Suppl 1 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |